Diabetes Treatment Devices Market Growth Potential: What The Latest Forecast Reveals
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Diabetes Treatment Devices Market Value Growth And Long-Term Outlook
The diabetes treatment devices market size has shown significant growth in recent years. It is anticipated to increase from $12.34 billion in 2025 to $13.11 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. Historically, this growth can be attributed to the reliance on traditional blood glucose meters, a limited understanding of self-monitoring devices, the expansion of hospital and diagnostic center infrastructure, the rising occurrence of diabetes, and the widespread use of standard lancets and testing strips.
The diabetes treatment devices market is set to observe significant expansion over the next few years. It is predicted to attain a value of $16.53 billion by 2030, progressing at a compound annual growth rate (CAGR) of 6.0%. This anticipated growth throughout the forecast period stems from factors such as the creation of smart insulin pens and pumps, the increasing adoption of real-time continuous glucose monitoring, the merging of technology with smartphones and wearable devices, the growth of remote patient monitoring initiatives, and the enlargement of diabetes clinics alongside online distribution channels. Prominent trends expected in this period include the escalating uptake of continuous glucose monitoring devices, a rising preference for intelligent insulin delivery systems, an increase in homecare and remote patient observation, the wider availability of wearable and portable glucometers, and an enhanced demand for safety-improved lancets and testing strips.
Get A Free Sample Report With In-Depth Market Insights:
Diabetes Treatment Devices Market Demand Drivers: What’s Powering Industry Growth?
The rising prevalence of obesity is projected to stimulate the expansion of the diabetes treatment devices market in the future. Obesity rate defines the proportion of individuals categorized as obese based on their body mass index (BMI). The growing obesity levels are primarily caused by unhealthy eating patterns rich in calories, sugars, and fats, leading to excessive weight gain when not balanced by physical activity. Diabetes treatment devices assist in reducing obesity rates by fostering improved blood sugar control, which in turn supports healthier lifestyle choices and weight management. For instance, in September 2024, according to the US Centers for Disease Control and Prevention (CDC), an US-based national public-health agency, adult obesity rates reached 35% or more in 23 US states in 2023, an increase from 22 states in 2022, indicating a worsening obesity situation. Therefore, increasing obesity rates are propelling the growth of the diabetes treatment devices market.
Diabetes Treatment Devices Market Segment Outlook: Which Categories Are Growing Fastest?
The diabetes treatment devices market covered in this report is segmented –
1) By Device Type: Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels
3) By End-User: Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users
Subsegments:
1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices, Non-Invasive Blood Glucose Monitoring Devices
2) By Self-Monitoring Devices: Handheld Glucometers, Wearable Self-Monitoring Devices
3) By Blood Glucose Meters: Standard Glucose Meters, Smart Or Connected Glucose Meters
4) By Testing Strips: Glucose Oxidase Strips, Glucose Dehydrogenase Strips
5) By Lancets: Standard Lancets, Safety Lancets
6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices, Intermittently Scanned Continuous Glucose Monitoring Devices
7) By Sensors: Short-Term Sensors, Long-Term Implantable Sensors
8) By Transmitters: Reusable Transmitters, Disposable Transmitters
9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors, Smartphone Or Smartwatch-Connected Receivers
10) By Other Device Types: Insulin Pens, Insulin Pumps, Smart Insulin Patches
Diabetes Treatment Devices Market Innovation Trends: What Developments Are Reshaping The Industry?
Leading firms within the diabetes treatment devices market are prioritizing the integration of sophisticated automation technologies, including automated insulin delivery algorithms, to boost the accuracy of treatment and maintain consistent glycemic control. Such algorithms utilize live glucose readings from continuous glucose monitoring sensors to automatically modify basal insulin dosages, thereby assisting in keeping glucose levels within the desired range with very little manual input. A notable example is Medtronic plc, a medical technology firm from the US, which secured FDA approval in April 2023 for its MiniMed 780G System. This automated insulin delivery technology aims to aid those with type 1 diabetes by automatically rectifying high glucose levels and adjusting insulin delivery every five minutes. The system incorporates SmartGuard technology for insulin adjustments that respond to real-time glucose changes, offers Bluetooth connectivity for mobile observation, and includes built-in continuous glucose monitoring support. The MiniMed 780G System contributes to enhanced treatment accuracy, greater glucose stability, and improved daily diabetes management results.
Diabetes Treatment Devices Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson And Company, Hoffmann-La Roche Ltd, Insulet Corporation, DexCom Inc, Tandem Diabetes Care Inc, Lifescan Inc, Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc, Bigfoot Biomedical Inc, Medtrum Technologies Inc, Diabeloop SA, Roche Diabetes Care GmbH, Insulet Inc, Omnipod Inc, Tandem Inc, Abbott Diabetes Care
View The Full Diabetes Treatment Devices Market Report:
Diabetes Treatment Devices Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the diabetes treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
